drugset / Trial / NCT00651612
Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluates the safety of brimonidine/timolol fixed combination in glaucoma or ocular hypertension patients
Timeline
- Start
- 2005-11
- Primary completion
- 2007-01
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brimonidine | Small molecule | 0.2 % | Other |
| Subject | Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution | Unknown | 0.2 % | Other |
| Subject | Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution | Unknown | 0.5 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |